A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells

Nature Immunology

Volumn 9, Issue 6, 2008, Pages 632-640

  Liu, Yongzhong ^a   Zhang, Pin ^a   Li, Jun ^a   Kulkarni, Ashok B ^b   Perruche, Sylvain ^a   Chen, WanJun ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ CD25+ FOXP3+ REGULATORY T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; GENE DELETION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE; THYMUS;

ANIMALS; B-CELL ACTIVATING FACTOR; CD4-POSITIVE T-LYMPHOCYTES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; MICE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 44049087148     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1607     Document Type: Article

References (51)

1. Bluestone, J.A. & Abbas, A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3, 253-257 (2003).
2. Fontenot, J.D. & Rudensky, A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6, 331-337 (2005).
3. reg cells: Guardians for life. Nat. Immunol. 8, 124-125 (2007).
4. Sakaguchi, S. Regulatory T cells: Key controllers of immunologic self-tolerance. Cell 101, 455-458 (2000).
5. Sakaguchi, S. & Powrie, F. Emerging challenges in regulatory T cell function and biology. Science 317, 627-629 (2007).
6. Schwartz, R.H. Natural regulatory T cells and self-tolerance. Nat. Immunol. 6, 327-330 (2005).
7. + suppressor T cells: More questions than answers. Nat. Rev. Immunol. 2, 389-400 (2002).
8. von Boehmer, H. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6, 338-344 (2005).
9. Waldmann, H., Adams, E., Fairchild, P. & Cobbold, S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol. Rev. 212, 301-313 (2006).
10. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
11. + T cells. Adv. Immunol. 81 331-371 (2003).
12. + T regulatory cells. Nat. Immunol. 4, 337-342 (2003).
13. Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3, 756-763 (2002).
14. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301-306 (2001).
15. van Santen, H.M., Benoist, C. & Mathis, D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200, 1221-1230 (2004).
16. + regulatory T cells in vivo. J. Exp. Med. 198, 249-258 (2003).
17. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440 (2000).
18. Tai, X., Cowan, M., Feigenbaum, L. & Singer, A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6 152-162 (2005).
19. + T regulatory cell development during the neonatal period. J. Exp. Med. 201, 769-777 (2005).
20. + regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6, 1152-1159 (2005).
21. Fontenot, J.D., Rasmussen, J.P., Gavin, M.A. & Rudensky, A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142-1151 (2005).
22. Malek, T.R. & Bayer, A.L. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4, 665-674 (2004).
23. Kulkarni, A.B. et al. Transforming growth factor-β null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90, 770-774 (1993).
24. Shull, M.M. et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693-699 (1992).
25. H17 and regulatory T cells. Nature 441, 235-238 (2006).
26. Carrier, Y., Yuan, J., Kuchroo, V.K. & Weiner, H.L. Th3 cells in peripheral tolerance. II. TGF-β-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity. J. Immunol. 178, 172-178 (2007).
27. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
28. + T regulatory cells. J. Immunol. 178, 4022-4026 (2007).
29. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149-5153 (2004).
30. - precursors. Am. J. Transplant. 4, 1614-1627 (2004).
31. - single positive T cells. Transplantation 82, 953-964 (2006).
32. Wan, Y.Y. & Flavell, R.A. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102, 5126-5131 (2005).
33. - cells to develop suppressive activity: The role of IL-2, TGF-β, and IL-10. J. Immunol. 172, 5213-5221 (2004).
34. Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219-1227 (2005).
35. + regulatory T cells. J. Exp. Med. 201, 1061-1067 (2005).
36. + regulatory T cells. J. Exp. Med. 201, 737-746 (2005).
37. Li, M.O., Sanjabi, S. & Flavell, R.A. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25, 455-471 (2006).
38. Marie, J.C., Liggitt, D. & Rudensky, A.Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor. Immunity 25, 441-454 (2006).
39. Hennet, T., Hagen, F.K., Tabak, L.A. & Marth, J.D. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. Proc. Natl. Acad. Sci. USA 92 12070-12074 (1995).
40. Larsson, J. et al. TGF-β signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro. Blood 102, 3129-3135 (2003).
41. Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387-396 (1996).
42. Fontenot, J.D., Dooley, J.L., Farr, A.G. & Rudensky, A.Y. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202, 901-906 (2005).
43. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296 (1998).
44. Surh, C.D., Sprent, J. & Webb, S.R. Exclusion of circulating T cells from the thymus does not apply in the neonatal period. J. Exp. Med. 177, 379-385 (1993).
45. Bonasio, R. et al. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat. Immunol. 7, 1092-1100 (2006).
46. Chen, W. et al. Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J. Exp. Med. 194, 439-454 (2001).
47. Shi, Y. & Massague, J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685-700 (2003).
48. Letterio, J.J. et al. Maternal rescue of transforming growth factor-β null mice. Science 264, 1936-1938 (1994).
49. Li, M.O., Wan, Y.Y., Sanjabi, S., Robertson, A.K. & Flavell, R.A. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 24, 99-146 (2006).
50. Yao, Z. et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109, 4368-4375 (2007).
51. Pennington, D.J. et al. Early events in the thymus affect the balance of effector and regulatory T cells. Nature 444, 1073-1077 (2006).